Bone marrow cellular niches are functional compartments that regulate haematopoietic stem cell (HSC) and immune cell behaviour through direct cell contact, growth factors and cytokines, and components of the extracellular matrix.
Within the bone marrow, HSCs are regulated by components of the vasculature, the trabecular bone and the surrounding stroma.
In addition to its role as a primary lymphoid organ through the support of lymphoid development, the bone marrow can act as a host for naive and memory immune cells, plasma cells, regulatory T cells and myeloid immune cells.
The bone marrow is heterogeneous with regard to perfusion, oxygenation and innervation. Together, studies exploring these features allow us to consider new ways in which the bone marrow cellular niches are constituted and regulated.
Because the haematopoietic and immune systems need to rapidly respond and adapt to the needs of the organism, their niches should not be viewed as static entities. For example, these niches can respond to particular states of injury and inflammation.
A better understanding of the dynamic interactions between HSCs, immune cells and their niches could yield significant therapeutic benefit in contexts such as chemotherapy, radiation injury or invasion of the niche by malignancies.
Progenitor cells that are the basis for all blood cell production share the bone marrow with more mature elements of the adaptive immune system. Specialized niches within the bone marrow guide and, at times, constrain the development of haematopoietic stem and progenitor cells (HSPCs) and lineage-restricted immune progenitor cells. Specific niche components are organized into distinct domains to create a diversified landscape in which specialized cell differentiation or population expansion programmes proceed. Local cues that reflect the tissue and organismal state affect cellular interactions to alter the production of a range of cell types. Here, we review the organization of regulatory elements in the bone marrow and discuss how these elements provide a dynamic means for the host to modulate stem cell and adaptive immune cell responses to physiological challenges.
Subscribe to Journal
Get full journal access for 1 year
only $22.08 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Scadden, D. T. The stem-cell niche as an entity of action. Nature 441, 1075–1079 (2006).
Schofield, R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4, 7–25 (1978).
Jones, D. L. & Wagers, A. J. No place like home: anatomy and function of the stem cell niche. Nature Rev. Mol. Cell Biol. 9, 11–21 (2008).
Dzierzak, E. & Speck, N. A. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nature Immunol. 9, 129–136 (2008).
Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121 (2005). This article showed that markers of the SLAM family are a useful tool that can be used to enrich for HSCs and progenitor cells. Using these markers, the authors showed that HSCs are present close to the sinusoidal endothelium in the bone marrow and the spleen. However, it was not determined whether this location represented a site of functional support of the cells (a niche) or a point of accumulation as the cells trafficked into and out of the bone marrow.
O'Malley, D. P. Benign extramedullary myeloid proliferations. Mod. Pathol. 20, 405–415 (2007).
Morita, Y. et al. Functional characterization of hematopoietic stem cells in the spleen. Exp. Hematol. 39, 351–359 (2011).
Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003). This study demonstrated that HSC numbers could be affected by genetic modulation of a specific set of osteolineage cells in the bone marrow microenvironment. It was the first demonstration of a specific cell type participating in a mammalian stem cell niche.
North, T. E. et al. Hematopoietic stem cell development is dependent on blood flow. Cell 137, 736–748 (2009).
Adamo, L. et al. Biomechanical forces promote embryonic haematopoiesis. Nature 459, 1131–1135 (2009).
Lancrin, C. et al. Blood cell generation from the hemangioblast. J. Mol. Med. 88, 167–172 (2010).
Sipkins, D. A. et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435, 969–973 (2005). Using in vivo confocal imaging, the authors identified specialized vascular microdomains within the bone marrow that contribute to HSPC and tumour cell engraftment.
Rafii, S., Mohle, R., Shapiro, F., Frey, B. M. & Moore, M. A. Regulation of hematopoiesis by microvascular endothelium. Leuk. Lymphoma 27, 375–386 (1997).
Mazo, I. B. et al. Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J. Exp. Med. 188, 465–474 (1998).
Kopp, H. G., Hooper, A. T., Avecilla, S. T. & Rafii, S. Functional heterogeneity of the bone marrow vascular niche. Ann. NY Acad. Sci. 1176, 47–54 (2009).
Ellis, S. L. et al. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 118, 1516–1524 (2011).
Butler, J. M. et al. Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell 6, 251–264 (2010).
Kobayashi, H. et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nature Cell Biol. 12, 1046–1056 (2010).
Sacchetti, B. et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324–336 (2007).
Mendez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829–834 (2010). The authors described nestin-expressing MSCs that reside exclusively in perivascular regions, are in close spatial relationship with HSCs and alter HSC function. They showed that HSCs and nestin-expressing MSCs constitute a bone marrow niche that can be regulated by hormones and the SNS.
Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12–CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988 (2006).
Omatsu, Y. et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 33, 387–399 (2010).
Naveiras, O. et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 460, 259–263 (2009).
Walkley, C. R. et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor γ deficiency. Cell 129, 1097–1110 (2007).
Grassinger, J., Haylock, D. N., Williams, B., Olsen, G. H. & Nilsson, S. K. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood 116, 3185–3196 (2010).
Lord, B. I. & Hendry, J. H. The distribution of haemopoietic colony-forming units in the mouse femur, and its modification by X rays. Br. J. Radiol. 45, 110–115 (1972).
Taichman, R. S. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105, 2631–2639 (2005).
Stier, S., Cheng, T., Dombkowski, D., Carlesso, N. & Scadden, D. T. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood 99, 2369–2378 (2002).
Fleming, H. E. et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2, 274–283 (2008).
Yoshihara, H. et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1, 685–697 (2007).
Qian, H. et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1, 671–684 (2007).
Arai, F. et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149–161 (2004).
Jung, Y. et al. Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation. Blood 110, 82–90 (2007).
Raaijmakers, M. H. et al. Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464, 852–857 (2010). The authors showed that deletion of the gene encoding the microRNA-processing enzyme Dicer in osteoprogenitor cells (but not in mature osteoblasts) induces myelodysplasia and secondary leukaemia in mice. These data revealed that primary changes in a tissue microenvironment can induce malignant transformation, supporting a concept of niche-induced oncogenesis. Broadly, the results indicate that specific mesenchymal cell populations are important in maintaining the integrity of parenchymal cell populations in some tissues.
Ferraro, F. et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci. Transl. Med. 3, 104ra101 (2011).
Jacome-Galarza, C. E., Lee, S. K., Lorenzo, J. A. & Aguila, H. L. Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow. J. Bone Miner. Res. 26, 1207–1216 (2011).
Stier, S. et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781–1791 (2005).
Nilsson, S. K. et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232–1239 (2005).
Adams, G. B. et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439, 599–603 (2006).
Kollet, O. et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nature Med. 12, 657–664 (2006).
Lymperi, S., Ersek, A., Ferraro, F., Dazzi, F. & Horwood, N. J. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117, 1540–1549 (2011).
Miyamoto, K. et al. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J. Exp. Med. 208, 2175–2181 (2011).
Chow, A. et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261–271 (2011).
Winkler, I. G. et al. Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815–4828 (2010).
Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R. & Link, D. C. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251–260 (2011).
Morita, Y., Ema, H. & Nakauchi, H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med. 207, 1173–1182 (2010). The authors transplanted single HSCs that had been selected on the basis of their levels of CD150 surface expression. They demonstrated that CD150hi HSCs provide enhanced myeloid reconstitution compared with CD150− HSCs, which are biased towards lymphoid reconstitution following transplantation. This article provided further support for evidence provided by multiple prior studies that heterogeneous populations of HSCs exist in the bone marrow.
Dykstra, B. et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1, 218–229 (2007).
Challen, G. A., Boles, N. C., Chambers, S. M. & Goodell, M. A. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1. Cell Stem Cell 6, 265–278 (2010).
Beerman, I. et al. Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc. Natl Acad. Sci. USA 107, 5465–5470 (2010).
Weber, J. M. & Calvi, L. M. Notch signaling and the bone marrow hematopoietic stem cell niche. Bone 46, 281–285 (2010).
Zhu, J. et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 109, 3706–3712 (2007).
Mansour, A. et al. Osteoclast activity modulates B-cell development in the bone marrow. Cell Res. 21, 1102–1115 (2011).
Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B. I. & Nagasawa, T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20, 707–718 (2004).
Peschon, J. J. et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955–1960 (1994).
Pereira, J. P., An, J., Xu, Y., Huang, Y. & Cyster, J. G. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nature Immunol. 10, 403–411 (2009).
Cariappa, A., Chase, C., Liu, H., Russell, P. & Pillai, S. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. Blood 109, 2339–2345 (2007).
Sapoznikov, A. et al. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nature Immunol. 9, 388–395 (2008). The authors showed that conditional deletion of DCs induces a profound reduction in B cell numbers in the bone marrow. This reduction was specific to recirculating mature B cells, as B cell development was unaffected by DC ablation. The authors showed that DCs, by producing MIF
Feuerer, M. et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nature Med. 9, 1151–1157 (2003).
Benner, R., Meima, F., van der Meulen, G. M. & van Muiswinkel, W. B. Antibody formation in mouse bone marrow. I. Evidence for the development of plaque-forming cells in situ. Immunology 26, 247–255 (1974).
Cassese, G. et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171, 1684–1690 (2003).
Benson, M. J. et al. Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. J. Immunol. 180, 3655–3659 (2008).
Nie, Y. et al. The role of CXCR4 in maintaining peripheral B cell compartments and humoral immunity. J. Exp. Med. 200, 1145–1156 (2004).
Chu, V. T. et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nature Immunol. 12, 151–159 (2011).
Winter, O. et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 116, 1867–1875 (2010).
Ma, Q., Jones, D. & Springer, T. A. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10, 463–471 (1999).
Hattori, K., Heissig, B. & Rafii, S. The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk. Lymphoma 44, 575–582 (2003).
Tokoyoda, K. et al. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30, 721–730 (2009).
Tokoyoda, K., Hauser, A. E., Nakayama, T. & Radbruch, A. Organization of immunological memory by bone marrow stroma. Nature Rev. Immunol. 10, 193–200 (2010).
Mazo, I. B. et al. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity 22, 259–270 (2005).
Fujisaki, J. et al. In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche. Nature 474, 216–219 (2011). The authors showed that particular periendosteal regions in the bone marrow are enriched for regulatory T cells that provide an immune-privileged site for HSCs.
Wilkins, B. S. Histology of normal haemopoiesis: bone marrow histology I. J. Clin. Pathol. 45, 645–649 (1992).
Eash, K. J., Greenbaum, A. M., Gopalan, P. K. & Link, D. C. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120, 2423–2431 (2010).
Kohler, A. et al. G-CSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117, 4349–4357 (2011).
Wang, Y. et al. CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J. Inflamm. 6, 32 (2009).
Parmar, K., Mauch, P., Vergilio, J. A., Sackstein, R. & Down, J. D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl Acad. Sci. USA 104, 5431–5436 (2007).
Winkler, I. G. et al. Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches. Blood 116, 375–385 (2010). Using a Hoechst dye to measure perfusion,the authors showed that HSCs that reside in hypoperfused areas display better reconstitution ability in serial transplantation assays.
Eliasson, P. & Jonsson, J. I. The hematopoietic stem cell niche: low in oxygen but a nice place to be. J. Cell Physiol. 222, 17–22 (2009).
Takubo, K. et al. Regulation of the HIF-1α level is essential for hematopoietic stem cells. Cell Stem Cell 7, 391–402 (2010). The authors showed that HIF1α is important for HSC numbers and quiescence.
Cipolleschi, M. G., Dello Sbarba, P. & Olivotto, M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82, 2031–2037 (1993).
Eliasson, P. et al. Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp. Hematol. 38, 301–310 (2010).
Wheaton, W. W. & Chandel, N. S. Hypoxia. 2. Hypoxia regulates cellular metabolism. Am. J. Physiol. Cell Physiol. 300, C385–C393 (2011).
Simsek, T. et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7, 380–390 (2010).
Kirito, K., Fox, N., Komatsu, N. & Kaushansky, K. Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1α. Blood 105, 4258–4263 (2005).
Gerber, H. P. et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417, 954–958 (2002).
Jogi, A. et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc. Natl Acad. Sci. USA 99, 7021–7026 (2002).
Mazumdar, J. et al. O2 regulates stem cells through Wnt/β-catenin signalling. Nature Cell Biol. 12, 1007–1013 (2010).
Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Med. 10, 858–864 (2004).
Wang, Y. et al. The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest. 117, 1616–1626 (2007).
Pedersen, M. et al. Stem cell factor induces HIF-1α at normoxia in hematopoietic cells. Biochem. Biophys. Res. Commun. 377, 98–103 (2008).
Bakker, W. J., Harris, I. S. & Mak, T. W. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol. Cell 28, 941–953 (2007).
Kojima, H. et al. Differentiation stage-specific requirement in hypoxia-inducible factor-1α-regulated glycolytic pathway during murine B cell development in bone marrow. J. Immunol. 184, 154–163 (2009).
Kojima, H. et al. Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice. Proc. Natl Acad. Sci. USA 99, 2170–2174 (2002).
Fukuda, R. et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205–38211 (2002).
Mignini, F., Streccioni, V. & Amenta, F. Autonomic innervation of immune organs and neuroimmune modulation. Auton. Autacoid Pharmacol. 23, 1–25 (2003).
Mendez-Ferrer, S., Lucas, D., Battista, M. & Frenette, P. S. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442–447 (2008). The authors showed that the release of HSCs into the bloodstream correlates with circadian fluctuations in noradrenaline secretion.
Elefteriou, F. et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514–520 (2005).
Schajnovitz, A. et al. CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nature Immunol. 12, 391–398 (2011).
Katayama, Y. et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407–421 (2006).
Lapid, K., Vagima, Y., Kollet, O. & Lapidot, T. Egress and mobilization of hematopoietic stem and progenitor cells. StemBook [online], (2009).
Spiegel, A. et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nature Immunol. 8, 1123–1131 (2007).
Nance, D. M. & Sanders, V. M. Autonomic innervation and regulation of the immune system (1987–2007). Brain Behav. Immun. 21, 736–745 (2007).
Harrison, D. E. & Lerner, C. P. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood 78, 1237–1240 (1991).
Birnberg, T. et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29, 986–997 (2008).
Keren, Z. et al. B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging. Blood 117, 3104–3112 (2011). The authors showed that the depletion of B cells in aged mice is followed by expansion of multipotent primitive progenitor and common lymphoid progenitor populations, suggesting the presence of a feedback mechanism.
Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L. & Weissman, I. L. Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933–1936 (2001).
Abkowitz, J. L., Robinson, A. E., Kale, S., Long, M. W. & Chen, J. Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 102, 1249–1253 (2003).
Bhattacharya, D. et al. Niche recycling through division-independent egress of hematopoietic stem cells. J. Exp. Med. 206, 2837–2850 (2009).
Sato, T. et al. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011).
Baldridge, M. T., King, K. Y. & Goodell, M. A. Inflammatory signals regulate hematopoietic stem cells. Trends Immunol. 32, 57–65 (2011). The authors used an in vivo mouse model of mycobacterial infection to demonstrate that HSPCs are responsive to systemic infection, as they proliferate in response to IFNγ signalling.
Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C. & Goodell, M. A. Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection. Nature 465, 793–797 (2010).
Essers, M. A. et al. IFNα activates dormant haematopoietic stem cells in vivo. Nature 458, 904–908 (2009).
Greenbaum, A. M. & Link, D. C. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 25, 211–217 (2010).
Shi, C. et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating Toll-like receptor ligands. Immunity 34, 590–601 (2011).
Singer, N. G. & Caplan, A. I. Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457–478 (2011).
Francois, M. et al. Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. Blood 114, 2632–2638 (2009).
Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nature Rev. Immunol. 7, 803–815 (2007).
Walkley, C. R., Shea, J. M., Sims, N. A., Purton, L. E. & Orkin, S. H. Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell 129, 1081–1095 (2007).
McCarthy, K. F., Ledney, G. D. & Mitchell, R. A deficiency of hematopoietic stem cells in steel mice. Cell Tissue Kinet. 10, 121–126 (1977).
Varnum-Finney, B. et al. Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. J. Clin. Invest. 121, 1207–1216 (2011).
Maillard, I. et al. Canonical Notch signaling is dispensable for the maintenance of adult hematopoietic stem cells. Cell Stem Cell 2, 356–366 (2008).
Cobas, M. et al. β-catenin is dispensable for hematopoiesis and lymphopoiesis. J. Exp. Med. 199, 221–229 (2004).
Visnjic, D. et al. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103, 3258–3264 (2004).
Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836–841 (2003).
Kiel, M. J., Radice, G. L. & Morrison, S. J. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 1, 204–217 (2007).
Wu, J. Y. et al. Osteoblastic regulation of B lymphopoiesis is mediated by Gsα-dependent signaling pathways. Proc. Natl Acad. Sci. USA 105, 16976–16981 (2008).
The authors would like to thank D. B. Sykes, L. Silberstein and I. Droujinine for their comments on the manuscript. Thanks also go to J.-P. Lévesque and S. Méndez-Ferrer for generously contributing to Fig. 3. F.E.M. is a recipient of a Clinician Scientist Training Award from the Canadian Institutes of Health Research. C.R. was funded by Massachusetts General Hospital institutional funds. This work was supported by the Ellison Medical Foundation and the National Heart, Lung and Blood Institute (grants U01HL10042 and R01HL44851).
David T. Scadden is a shareholder in Fate Therapeutics and a consultant to Genzyme, Hospira and Fate Therapeutics.
Francois E. Mercier and Christine Ragu have no competing financial interests.
A phase in the cell cycle in which the cell is not dividing or preparing to divide but still has the ability to do so in the presence of an appropriate signal.
Specialized blood vessels that are similar to capillaries, but are lined by endothelial cells with fenestrations that allow the passage of cells and large molecules.
- Adventitial cells
Connective tissue cells that surround small blood vessels and have a supportive structural role and possibly other functions, such as blood flow regulation.
- Trabecular bone
A network of bony projections that is present at the ends of long bones and forms a highly vascularized, porous matrix that is the main site of haematopoiesis in adults.
(Also known as SP7). A zinc finger-containing transcription factor that is required for the commitment of mesenchymal cells to the osteoblastic lineage.
This gene encodesDicer, an endoribonuclease that cleaves double-stranded RNA and is important for processing pre-microRNAs.
- Epigenetic changes
Modifications in the activation state of certain genes that persist following cell division. These alterations are not related to changes in DNA sequence, but are induced through other mechanisms, such as DNA methylation and histone modifications.
- T cell-independent antigens
Antigens that do not require T cell help to induce specific antibody production. These antigens are commonly polymeric antigens, such as polysaccharides and lipids.
- Splenic marginal zone
An area in the spleen with the major function of trapping circulating antigens. The marginal zone is populated by a distinct population of lymphocytes that can be readily activated following exposure to blood-borne pathogens.
- CD34+CD38− progenitor cells
A population of cells within the human haematopoietic system that is defined by the expression of cell-surface markers and is enriched in stem cells and progenitors.
About this article
Cite this article
Mercier, F., Ragu, C. & Scadden, D. The bone marrow at the crossroads of blood and immunity. Nat Rev Immunol 12, 49–60 (2012). https://doi.org/10.1038/nri3132
Current Osteoporosis Reports (2020)
The Allergic Bone Marrow? The Immuno-Capacity of the Human Bone Marrow in Context of Metal-Associated Hypersensitivity Reactions
Frontiers in Immunology (2019)
Cell Reports (2019)
Association of bone mineral density with hemoglobin and change in hemoglobin among older men and women: The Cardiovascular Health Study
Drug Discovery Today (2019)